Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2022 | Story Lacea Loader

From 24 February 2022 – as an interim solution to the challenges experienced with the disruption of classes on the University of the Free State (UFS) Bloemfontein Campus during the week of 21 February 2022 – the academic programme will continue in a differentiated and flexible online mode in some modules within faculties.

Face-to-face classes will continue in those modules where online teaching is not possible at this stage. Students will be informed by their respective faculties as to which modules will be moving online, and which will remain face to face.

This is a temporary measure to enable the campus to return to stability. The arrangement is estimated to continue for two to three weeks at the most, after which the academic programme will return to the approved teaching plans for 2022.

As an additional measure and to mitigate the challenges of remote off-campus internet access, 10 GB of data is provided free of charge through Global Protect to all registered students for the next month. This will enable students to link to learning resources off campus at no cost. The use of social media is, however, not included in the 10 GB.

Enquiries regarding GlobalProtect can be directed to the ICT Services Call Centre at +27 51 401 9111 (option 4).

Computer laboratories on the campus will remain available to vaccinated students whose modules will be moving online.

Issued by:
Lacea Loader
Director: Communication and Marketing
University of the Free State
loaderl@ufs.ac.za

23 February 2022

News Archive

UFS cardiac team does pioneering work
2017-10-29

Description: ' 000 Cardiac Pioneers Tags: Cardiac Pioneers 

“With the use of endomyocardial biopsies, the team hopes to treat viruses unique
to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

Photo: iStock

Members of the University of the Free State’s (UFS) Cardiac team had various achievements at national and international level this year. The Robert WM Frater Cardiovascular Research Centre in the Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.

With an Afrocentric research focus, Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition, and 50% of patients who have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made, where virus infections of the heart muscle, or myocarditis, have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

According to Prof Mokoali Makotoko, Head of the Department of Cardiology, more than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies, the team hopes to treat viruses unique to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

The study is a project that flows from Prof Makotoko’s PhD. The project is being run with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

 "More than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept